Marketta Kähkönen Selected Research

DNA (Deoxyribonucleic Acid)

2/2015

Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marketta Kähkönen Research Topics

Disease

3	Neoplasms (Cancer) 01/2014 - 03/2004
1	Complementation Group D1 Fanconi Anemia 02/2015
1	Fanconi Syndrome (Syndrome, Fanconi) 02/2015
1	Anemia 02/2015
1	Breast Neoplasms (Breast Cancer) 02/2015
1	Glioma (Gliomas) 01/2014
1	Fibrosarcoma 07/2012
1	Pathologic Complete Response 07/2012
1	Heart Neoplasms 07/2012
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2009
1	Hypoxia (Hypoxemia) 01/2008
1	Brain Neoplasms (Brain Tumor) 01/2008
1	Lymphoma (Lymphomas) 03/2004
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2004
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2004

Drug/Important Bio-Agent (IBA)

1	Fanconi Anemia Complementation Group ProteinsIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Docetaxel (Taxotere)FDA Link 07/2012
1	Gemcitabine FDA Link 07/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2012
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2012
1	Dasatinib (BMS 354825)FDA Link 10/2009
1	Indicators and Reagents (Reagents)IBA 01/2008
1	Superoxide DismutaseIBA 01/2008
1	Carbonic Anhydrase IXIBA 01/2008
1	EnzymesIBA 01/2008
1	Ligases (Synthetase)IBA 01/2008
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2004

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2014 - 10/2009
1	Radiotherapy 01/2014
1	Therapeutics 01/2014
1	Adjuvant Chemotherapy 07/2012